Medical Xpress January 9, 2025
The Francis Crick Institute

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed treatment decisions for people with stage 1 lung cancer, potentially reducing the risk of the cancer returning or spreading.

In research published in Nature Cancer, the team tested ORACLE in 158 people with lung cancer as part of the TRACERx study. They found that ORACLE could better predict than currently used clinical standards like .

ORACLE was developed in 2019 to overcome the lack of biological markers in lung cancer, which can indicate to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Provider
GenAI is already transforming the healthcare industry
Where Medicaid cuts stand
Q&A: Rural hospitals need help with cybersecurity survival
Radiology provider MedQuest part of deal to acquire 18 imaging centers from 1 of nation’s largest orthopedic groups
ASC block utilization by specialty

Share This Article